PCN19 AUSTRALIAN COST-EFFECTIVENESS ANALYSIS OF ANASTROZOLEVSTAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER BASED ON THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL
Abstract
Authors
A Benedict D Theodoratou A Maclean S Norris S Campbell P Mernagh